MAC-LINE 02/CO2 NASAL CANNULA SAMPLE LINE

K012395 · Oridion Medical 1987 , Ltd. · CCK · Aug 15, 2001 · Anesthesiology

Device Facts

Record IDK012395
Device NameMAC-LINE 02/CO2 NASAL CANNULA SAMPLE LINE
ApplicantOridion Medical 1987 , Ltd.
Product CodeCCK · Anesthesiology
Decision DateAug 15, 2001
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 868.1400
Device ClassClass 2
AttributesPediatric

Intended Use

The intended use of the MAC-Line Oz/CO2 Nasal Cannula sample line is to conduct a sample of the adult/pediatric subject's breathing from the subject, via a nasal cannula, to a gas measurement device (capnograph) while simultaneously administering supplemental oxygen projected near the nose and mouth for inhalation.

Device Story

Device is a combination nasal cannula for simultaneous CO2 gas sampling and supplemental oxygen delivery. Input: patient exhaled breath (for CO2 monitoring) and external oxygen supply (for inhalation). Operation: nasal cannula interfaces with patient nose; Microstream sample tube connects to capnograph; separate tube with standard connector links to oxygen source. Used in clinical settings for non-intubated patients. Output: gas sample delivered to capnograph for analysis; oxygen delivered to patient. Benefits: enables continuous capnography monitoring while providing respiratory support. Healthcare providers use capnograph output to assess patient ventilation status and adjust clinical management accordingly.

Clinical Evidence

Bench testing only. Biocompatibility testing included physicochemical tests, cytotoxicity (ISO elution method), sensitization (ISO maximization method in guinea pigs), and acute intracutaneous reactivity (in rabbits).

Technological Characteristics

Combination nasal cannula; CO2 sampling line with Luer lock; O2 delivery line with standard connector bushing. Materials tested for biocompatibility per ISO standards. Standalone mechanical device; no software or electronics.

Indications for Use

Indicated for adult and pediatric non-intubated subjects requiring CO2 measurement via nasal cannula and simultaneous supplemental oxygen administration.

Regulatory Classification

Identification

A carbon dioxide gas analyzer is a device intended to measure the concentration of carbon dioxide in a gas mixture to aid in determining the patient's ventilatory, circulatory, and metabolic status. The device may use techniques such as chemical titration, absorption of infrared radiation, gas chromatography, or mass spectrometry.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ # AUG 1 5 2001 Image /page/0/Picture/1 description: The image shows the logo for Oridion. The logo consists of a stylized globe made up of horizontal lines, positioned above the word "Oridion" in a serif font. The globe is black and white, and the text is black. 2/2395 בס"ד # 3.0 510(k) Summary Product name Proprietary: MAC-Line O₂/CO₂ Nasal Cannula sample line Common: Nasal Cannula Gas sampling line for capnograph with integrated Oxygen Administration means for simultaneously administering supplemental oxygen projected near the nose and mouth for inhalation. Establishment registration number Establishment registration number: 8044004 Establishment Address: ORIDION MEDICAL 1987 LTD. HAR HOTZVIM SCIENCE BASED INDUSTRIAL PARK POB 45025 91450 JERUSALEM, ISRAEL Device Listing Fda Form 2892: A 733250 Product classification The MAC-Line Q2/CO2 Nasal Cannula sample line is classified as Class II according to 21CFR868.1400 (73CCK) #### INTENDED USE: The intended use of the MAC-Line Oz/CO2 Nasal Cannula sample line is to conduct a sample of the adult/pediatric subject's breathing from the subject, via a nasal cannula, to a gas measurement device (capnograph) while simultaneously administering supplemental oxygen projected near the nose and mouth for inhalation. #### DEVICE DESCRIPTION The common product name for this device is Nasal Cannula Gas sampling line for capnograph with integrated Oxygen Administration means for simultaneously administering supplemental oxygen projected near the nose and mouth for inhalation. The complete device is a combined device consisting of two devices, as described below, integrated to simultaneously perform the function of both devices Oridion Medical 1987 Ltd. • POB 45025 • Jerusalem 91450 Israel • Voice:+972 2 589-9115 • Fax:+972 2 582-8873 {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows the logo for Oridion. The logo consists of a stylized globe-like shape above the word "Oridion" in a serif font. The globe is made up of curved lines, giving it a textured appearance. The overall design is simple and professional. בס"ד The CO2 gas sampling nasal cannula is used with a capnograph (carbon dioxide analyzer 21CFR 868.1400). There is a nasal cannula at one end of the device for connecting to the patient's nose, a Microstream sample tube with a Male or Female Luer lock on the other end for connecting to the capnograph. The CO2 Cannula is identical to the Oridion CO2 Nasal Cannula K980325. Attached and integrated with the CO2 nasal cannula is another device for simultaneously administering supplemental oxygen projected near the nose and mouth for inhalation. The O₂ cannula has a tube with a standard O₂ connector bushing on the end for connecting to a normal O2 supply. The O2 device is classified as class I according to 21CFR868.5340. ## PREDICATE DEVICE There are three predicate devices: - The Oridion O2/CO2 predicate device is the Microstream O2/CO2 . Nasal Cannula Filterline. - The Adult predicate device is the Hospitak disposable CO2 Gas . sampling/Oxygen delivery Cannula K915228. - The Pediatric predicate device is the Salter Laboratories Model . 4701 CO2 Gas sampling/Oxygen delivery Cannula. ## SUBSTANTIAL EQUIVALENCE: The MAC-Line O2/CO2 Nasal Cannula sample line is a combination device that combines a CO2 sampling nasal cannula with a O2 supply nasal cannula. - . The MAC-Line O2/CO2 Nasal Cannula sample line is essentially equivalent to the Hospitak disposable CO2 Gas sampling/Oxygen delivery Cannula K915228. - The Oridion Pediatric MAC-Line O2/CO2 Nasal Cannula sample . line is essentially equivalent to the Salter Laboratories Model 4701 CO2 Gas sampling/Oxygen delivery Cannula {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows the word "Oridion" in a serif font, with each letter clearly legible. Above the word, there is a stylized graphic that resembles a sphere or globe. The sphere is composed of multiple layers or segments, giving it a textured, three-dimensional appearance. ### בש"ד BIOCOMPATIBILITY #### Requirements The parts of this product which comes into contact with the patient's nose have been tested for biocompatibility. The methods used for testing were: - 1. Physicochemical tests, plastics, complete (Aqueous exfract) - 2. Cytotoxicity study using the ISO elution method (Extract) - 3. ISO Sensitization test in 15 Guinea Pigs, per extract (Maximization method) Saline Extract, Cottonseed Extract - 4. ISO Acute Intracutaneous Reactive study in three rabbits, Saline Extract, Cottonseed Extract. - 5. Detailed reports are found in Appendix A {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is a stylized symbol that resembles three overlapping waves or lines. #### Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 AUG 1 5 2001 Mr. Sanford Brown Regulatory Affairs Manager Oridion Medical 1987 Ltd. P.O. Box 45025 Jerusalem 91450 Israel K012395 Re: Mac-Line O, /CO, Nasal Cannula Sample Line Regulation Number: 868.1400 Regulatory Class: II (two) Product Code: 73 CCK Dated: July 23, 2001 Received: July 27, 2001 Dear Mr. Brown: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {4}------------------------------------------------ Page 2 - Mr. Sanford Brown This letter will allow you to begin marketing your device as described in your 510(k) premarket I ntil letter . The FDA finding of substantial equivalence of your device to a legally marketed notheated wice results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, Darth Tilla James F. Dillard III mes E. I Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ Image /page/5/Picture/0 description: The image shows the word "Oridion" in a serif font, with each letter clearly legible. Above the word, there is a stylized, abstract graphic that resembles a sphere or globe. The sphere is composed of curved lines or segments, giving it a textured, three-dimensional appearance. The overall design is simple and clean, with a focus on the text and the distinctive graphic element. בס"ד # 5.0 INDICATIONS FOR USE FORM 510(k) Number (if known): _ K Olz 3 9 5 Device Name: MAC-Line O2/CO2 Nasal Cannula sample line Indications For Use: The MAC-Line O2/CO2 Nasal Cannula sample line device is used whenever the physician needs to measure the CO2 in an adult or pediatric non intubated subject's breathing via a nasal cannula while simultaneously administering supplemental oxygen near the nose and mouth for inhalation. ## (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use _____________________________________________________________________________________________________________________________________________________________ OR Over-The-Counter Use (Per 21 CFR 801.109) (Optional Format 1-2-96) Division of Cardiovascular & Respiratory Devices 510(k) Number Dale Tell K02345 Oridion Medical 1987 Ltd. • POB 45025 • Jerusalem 91450 Israel • Voice:+972 2 589-9115 • Fax:+972 2 582-8873
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%